证券日报网讯 1月8日，新开源（300109）发布公告称，公司将于2026年1月27日召开2026年第二次临时 股东大会。 ...

Group 1 - Dongcheng Pharmaceutical announced a commitment to a stock repurchase loan of up to 170 million yuan [2][4] - Xin Kaiyuan plans to repurchase shares worth between 40 million to 50 million yuan for cancellation [2][4] Group 2 - Zhongwei Company’s major shareholder, Xunxin Investment and Chairman Yin Zhiyao, intends to reduce their holdings by up to 2.05% [5] - *ST Jianyi's shareholder Sun Yun plans to reduce holdings by up to 1.23% [5] - Hongrun Construction's shareholder Zhou Meizhen plans to reduce holdings by up to 0.12% [5] - ST Yigou's shareholder Hangzhou Haoyue reduced holdings by 20.22 million shares from January 5 to 8 [5] - Huafeng Measurement and Control's financial director plans to reduce holdings by up to 0.0021% [5] - Zhukebo Design's shareholder intends to reduce company shares [5] - Taifengquan's shareholders Hongtai Investment and Yitai Investment plan to reduce holdings by up to 0.54% [5] - Lai Yifen's controlling shareholder Aiwuqi Management plans to reduce holdings by up to 3% [5] - Jialitu's shareholder Anle Group plans to reduce holdings by up to 3% [5] - Hu Silicon Industry's largest shareholder, the National Integrated Circuit Industry Investment Fund, reduced holdings by 0.2% from January 7 to 8 [5] - Yuguang Jinchang's shareholder Investment Group plans to reduce holdings by up to 1.71% [5]

证券日报网讯 1月8日，新开源发布公告称，公司第五届董事会第二十一次会议审议通过《关于以集中 竞价交易方式回购公司股份方案的议案》《关于提请股东大会授权董事会办理公司回购股份相关事宜的 议案》《关于召开2026年第二次临时股东大会的议案》。 （文章来源：证券日报） ...

Group 1 - The company plans to repurchase shares through centralized bidding, with a repurchase amount between 40 million and 50 million yuan, and a maximum repurchase price of 25.77 yuan per share, which is 50.88% higher than the current price of 17.08 yuan [1] - The repurchase is expected to stabilize the stock price and can be used for employee stock ownership plans or equity incentive plans [1] - The company is involved in the research, production, and sales of high-value pharmaceutical excipients and in vitro diagnostic services, with its main business revenue composition including PVP other (39.57%), PVPK30 powder (28.35%), and early cancer diagnosis services (3.08%) [1] Group 2 - As of December 10, the number of shareholders is 18,900, a decrease of 5.03%, while the average circulating shares per person increased by 5.30% to 23,825 shares [2] - For the period from January to September 2025, the company reported a revenue of 951 million yuan, a year-on-year decrease of 14.36%, and a net profit attributable to the parent company of 201 million yuan, down 35.39% year-on-year [2] - The company has distributed a total of 900 million yuan in dividends since its A-share listing, with 607 million yuan distributed in the last three years [3]

Suspension - ChuanYin High-Tech: China Seed Group intends to acquire 298 million shares, stock to resume trading [1] - HuiBoPu: Water Industry Group plans to transfer 25%-30% of company shares, stock suspended [1] - TianSheng New Materials: Major shareholder Wu Haizhou is planning significant matters that may lead to a change in control, stock suspended [2] Private Placement and Mergers - RiJiu Optoelectronics: Plans to raise no more than 800 million yuan for a project to produce 6 million square meters of functional films and to supplement working capital [3] - QuanXin Co., Ltd.: Plans to issue convertible bonds to raise no more than 1.2 billion yuan for the production of integrated products for commercial aviation transmission and communication [3] - BeiFang ChangLong: Plans to acquire 51% of Shunyi Technology, expected to constitute a major asset restructuring [3] Share Buybacks - XingChen Technology: Plans to repurchase shares for 60 million to 120 million yuan, with a maximum repurchase price of 88.90 yuan per share [4] - XinKaiYuan: Plans to repurchase shares for 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [4] External Investments and Daily Operations - RunJian Co., Ltd.: Signed a strategic cooperation framework agreement with JD Technology to expand cooperation in AI applications and intelligent computing cloud [4] - YueDianLi A: The expansion project of Huizhou Power Plant Units 5 and 6 (2×1000MW) has a total investment of 8.05 billion yuan, with Unit 5 now in operation [5] - ZhongWu Drone: Signed a contract for drone systems worth over 100 million yuan, expected to positively impact annual operating performance [6] - TianNeng Co., Ltd.: Plans to use no more than 12 billion yuan of self-owned funds for entrusted wealth management [7] - ChangHong Technology: Its subsidiary has secured over half of the procurement share from a major domestic wafer factory for semiconductor consumables by 2026 [7] - AiMeiKe: Exclusive distributor of injectable type A botulinum toxin products has obtained drug registration certificate [7] - KangTai Biology: Clinical trial application for acellular pertussis-diphtheria-tetanus combined vaccine has been accepted [8] - PaiRui Co., Ltd.: Signed a framework agreement for bulk procurement of IGBT chips, with total supply amounting to approximately 1.3 to 1.4 billion yuan for 2028, 2029, and 2030 [8] Performance Changes - JinLi YongCi: Expected net profit of 660 million to 760 million yuan in 2025, a year-on-year increase of 127%-161% due to small batch deliveries of robotic motor rotors and magnetic materials [9] - YingQu Technology: Expected net profit of 540 million to 660 million yuan in 2025, a year-on-year increase of 114.69%-162.40%, with significant fair value changes from equity investments expected to add 381 million yuan to net profit [9] - AiBiSen: Expected net profit of 240 million to 290 million yuan in 2025, a year-on-year increase of 105.32%-148.09% [9] - WenShi Co., Ltd.: Expected net profit in 2025 to decrease by 40.73%-46.12% year-on-year due to declining profits in pig and chicken farming [9]

北京商报讯（记者 丁宁）1月8日晚间，新开源（300109）发布公告称，基于对公司未来发展的信心和 对公司价值的认可，为增强投资者对公司的投资信心，维护广大股东利益，公司拟使用自有资金以集中 竞价交易方式回购部分公司股份，用于注销并减少注册资本。回购股份的资金总额不低于4000万元（含 本数）且不超过5000万元（含本数）。 ...

Group 1 - Jinli Permanent Magnet expects a net profit of 660 million to 760 million yuan for 2025, representing a year-on-year growth of 127% to 161% [1] - Wens Foodstuffs anticipates a net profit of 5 billion to 5.5 billion yuan for 2025, a decrease of 40.73% to 46.12% compared to the previous year [2] - New Open Source plans to repurchase shares worth 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [3] Group 2 - Fosun Pharma's subsidiary has had a drug registration application accepted for a new drug targeting ALK-positive non-small cell lung cancer [4] - Leike Film reported a net profit of -86 million yuan for the first three quarters of 2025, indicating a potential annual loss [5] - Crown Stone Technology's application for a specific issuance of A-shares has been accepted by the Shanghai Stock Exchange [6] Group 3 - Dongxin Technology has completed the business registration change for its subsidiary, Lishuan Technology, and has invested 211 million yuan in it [7] - Tianci Materials has increased its commodity futures hedging business limit from 150 million to 300 million yuan [8] - Gaode Infrared's actual controller has reduced his shareholding by 0.54%, bringing his stake down to 62.95% [9] Group 4 - Tianyong Intelligent expects a net profit of 10 million to 15 million yuan for 2025, marking a turnaround from losses [10][11] - China Merchants Energy anticipates a net profit of 6 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year [18] - Guangdong Electric Power A's Huizhou Power Plant's Unit 5 has been put into commercial operation, with an investment of 8.05 billion yuan [19] Group 5 - Jianghuai Automobile reported a 42.24% year-on-year increase in sales volume for December 2025 [25] - China Pharmaceutical's subsidiary has received a drug registration certificate for a new medication [26] - TianNeng Co. plans to use up to 12 billion yuan of its own funds for entrusted wealth management [27] Group 6 - Luoyang Huizhong reported a 10.55% month-on-month decrease in sales revenue from live pigs for December 2025 [28] - Baolidi expects a net profit of 145 million to 152 million yuan for 2025, a year-on-year increase of 27.17% to 33.30% [30] - Changchun High-tech's subsidiary has had a melatonin granule registration application accepted [31] Group 7 - Zhongmin Energy reported a 4.46% year-on-year decrease in cumulative on-grid electricity for 2025 [32] - Huaxin Electronics reported a 7.79% year-on-year decrease in consolidated operating revenue for December 2025 [35] - Xiamen Airport reported a 2.79% year-on-year increase in passenger throughput for December 2025 [36] Group 8 - Baiyun Airport reported a 12.27% year-on-year increase in passenger throughput for December 2025 [37] - Pulaike has received a new veterinary drug registration certificate for a chewable tablet [38] - Yunnan Energy Holdings' subsidiary has reduced its stake to 84% after a capital increase [39] Group 9 - Gansu Energy Chemical's new thermal power project has successfully completed trial operation [41] - Zhenghong Technology reported a significant decrease in sales revenue from live pigs for December 2025 [42] - Huasheng Lithium Battery is planning to issue H-shares for listing on the Hong Kong Stock Exchange [43] Group 10 - Jincheng Mining has signed a mining production contract with an estimated total price of approximately 510 million yuan [44] - Microchip Biotech has received approval for clinical trials of a new drug for pancreatic cancer [45] - Yahon Pharmaceutical has completed the first patient enrollment for a Phase I clinical trial of its drug [46]

每经头条（nbdtoutiao）——培训5天就考证！滑雪教练速成班乱象调查：零基础也可报名，学时还 能"注水" 每经AI快讯，新开源1月8日晚间发布公告称，公司第五届第二十一次董事会会议于2026年1月7日在公 司三楼会议室以现场加通讯的表决方式召开。会议审议了《关于以集中竞价交易方式回购公司股份方案 的议案》等文件。 （记者 曾健辉） ...

格隆汇1月8日丨新开源(300109.SZ)公布，公司本次回购的公司股份将全部用于注销并减少注册资本。 回购股份的资金总额不低于人民币4,000万元（含本数）且不超过人民币5,000万元（含本数），具体以 回购期限届满时实际使用的资金总额为准。回购价格上限为25.77元/股。 ...

新开源（300109）(300109.SZ)公告，公司拟回购公司股份用于注销并减少注册资本。回购股份的资金 总额不低于4000万元(含本数)且不超过5000万元(含本数)。回购价格上限为25.77元/股。回购股份的期限 自公司股东大会审议通过本次回购方案之日起6个月内。 ...